Cintas Corporation vs Teladoc Health Inc — how do they compare? Cintas Corporation trades at $202.41 (market cap $79.86B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Cintas Corporation is far larger — about 79.1× Teladoc Health Inc's market cap, and Cintas Corporation pays a 1.03% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cintas Corporation for 125 Days and Teladoc Health Inc for 39 Days on average.
| CTAS | TDOC | |
|---|---|---|
Market Cap | $79.86B | $1.01B |
Volume | 1,323,583 | 4,668,477 |
Sector | Industrials | Health |
52-Week High | $216.53 | $9.72 |
52-Week Low | $163.55 | $4.47 |
Typical Hold Time | 125 Days | 39 Days |
Enterprise Value | $82.33B | $1.27B |
Dividend Yield | 1.03% | — |
Signals from Pluang's Aura AI — not financial advice
Cintas (CTAS) trades at $201.12, up 1.99% today, with strong technical momentum above key support levels. The company demonstrates robust fundamentals with Q1 2027 revenue exceeding $3 billion for the first time, 10.9% organic growth, and raised fiscal 2027 guidance. Profit margins remain industry-leading with 50.99% gross margin and 17.82% net income margin, though valuation metrics appear elevated with a P/E of 39.67.
The outlook remains positive with consistent earnings beats and strong analyst support, though high valuation multiples and competitive pressures present risks. With 40% of analysts maintaining buy ratings and a consensus price target of $234.60 representing 16.6% upside, the stock offers growth potential but requires monitoring of margin sustainability and market multiple compression risks.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →